CIBC Asset Management Inc increased its position in Amrize Ltd (NYSE:AMRZ – Free Report) by 345.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 26,677 shares of the company’s stock after acquiring an additional 20,684 shares during the quarter. CIBC Asset Management Inc’s holdings in Amrize were worth $1,443,000 at the end of the most recent quarter.
A number of other hedge funds have also modified their holdings of the company. Rothschild Investment LLC lifted its stake in shares of Amrize by 4.3% during the 4th quarter. Rothschild Investment LLC now owns 6,835 shares of the company’s stock valued at $370,000 after buying an additional 280 shares in the last quarter. FNY Investment Advisers LLC increased its stake in Amrize by 9.8% in the 4th quarter. FNY Investment Advisers LLC now owns 5,690 shares of the company’s stock worth $307,000 after buying an additional 510 shares in the last quarter. Basepoint Wealth LLC bought a new stake in Amrize during the fourth quarter valued at about $33,000. Laurel Wealth Advisors LLC bought a new stake in Amrize during the fourth quarter valued at about $34,000. Finally, State of Wyoming purchased a new position in shares of Amrize in the third quarter valued at about $32,000.
Insider Buying and Selling at Amrize
In other Amrize news, CTO Roald Brouwer bought 3,000 shares of the firm’s stock in a transaction dated Wednesday, March 11th. The shares were purchased at an average cost of $58.72 per share, for a total transaction of $176,160.00. Following the transaction, the chief technology officer owned 16,257 shares of the company’s stock, valued at $954,611.04. This represents a 22.63% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Nollaig Forrest purchased 2,000 shares of the stock in a transaction that occurred on Friday, May 22nd. The stock was acquired at an average cost of $50.25 per share, with a total value of $100,500.00. Following the acquisition, the insider owned 20,139 shares in the company, valued at $1,011,984.75. The trade was a 11.03% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last ninety days, insiders bought 64,120 shares of company stock valued at $3,239,187. 0.54% of the stock is owned by company insiders.
Amrize Trading Down 5.2%
Amrize (NYSE:AMRZ – Get Free Report) last released its quarterly earnings results on Wednesday, April 29th. The company reported ($0.16) earnings per share for the quarter, missing the consensus estimate of ($0.14) by ($0.02). Amrize had a net margin of 9.70% and a return on equity of 9.84%. The firm had revenue of $2.18 billion for the quarter. Amrize’s revenue was up 4.7% on a year-over-year basis. Equities research analysts predict that Amrize Ltd will post 2.76 EPS for the current fiscal year.
Amrize Cuts Dividend
The firm also recently announced a dividend, which was paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th were issued a $0.11 dividend. The ex-dividend date of this dividend was Tuesday, May 12th. Amrize’s dividend payout ratio (DPR) is 21.05%.
Analyst Upgrades and Downgrades
AMRZ has been the subject of a number of recent analyst reports. Weiss Ratings lowered Amrize from a “hold (c+)” rating to a “hold (c)” rating in a research note on Monday, May 18th. JPMorgan Chase & Co. boosted their price target on Amrize from $60.00 to $70.00 and gave the stock an “overweight” rating in a report on Thursday, March 5th. Berenberg Bank set a $70.00 price target on Amrize in a research note on Thursday, February 19th. Vertical Research raised shares of Amrize from a “hold” rating to a “buy” rating and set a $70.00 price objective for the company in a report on Friday, May 1st. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Amrize in a research report on Monday, February 23rd. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $64.86.
View Our Latest Analysis on AMRZ
Amrize Profile
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Recommended Stories
- Five stocks we like better than Amrize
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ – Free Report).
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
